✦ LIBER ✦

In vitro study of SCH 66336, a farnesyltransferase inhibitor, in non-small cell lung cancer (NSCLC) cell lines

✍ Scribed by Loprevite, M; Favoni, R; Mazzanti, P; de Cupis, A; Pirani, P; Ardizzoni, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis inhibitors in the treatment

✍ Enric Carcereny Costa; Núria Viñolas Segarra; Pere Gascón Vilaplana 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 153 KB

Effects of gemcitabine on cell prolifera

✍ E. Pace; M. Melis; L. Siena; F. Bucchieri; A. M. Vignola; M. Profita; M. Gjomark 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 337 KB

Second line chemotherapy (CT) in advance

✍ Westeel, V.; Jacoulet, P.; Dubiez, A.; Polio, J.C.; Pemet, D.; Depierre, A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Phase II study of gemcitabine in non sma

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Non-small cell lung cancer (NSCLC): A ma

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Ras homologue enriched in brain is a cri

✍ Hang Zheng; Anling Liu; Bin Liu; Minghui Li; Hailang Yu; Xiaojun Luo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 834 KB